S. Korea Newspaper Says Pfizer Korea Not Candid About Champix Effects
This article was originally published in PharmAsia News
Executive Summary
Pfizer Korea has been accused in a newspaper report of being less than candid about the side effects of its Champix (varenicline) anti-smoking drug. The Korea Times quoted Pfizer Korea as saying it reported all side effects to Korea FDA, but would not say what they were. The newspaper cited various conclusions by government authorities critical of the drug, some saying that although it is approved for eliminating the curb the desire to smoke, it is implicated in suicides and other deaths after use. (Click here for more